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AbstrAct
Objectives Circulating 25-hydroxyvitamin D (25-OHD) 
is associated with improved cancer prognosis in some 
studies, yet it may be a surrogate marker for physical 
activity. We investigated the associations of leisure-time 
physical activity (LTPA) with circulating 25-OHD levels in 
cancer survivors, and determined whether associations 
differ by indoor and outdoor activity.
Design Cross-sectional study.
Setting The US National Health and Nutrition Examination 
Survey (NHANES).
Participants Cancer survivors with available data on 
demographic information, measures of adiposity, smoking 
history, self-reported LTPA and circulating 25-OHD levels in 
five waves of NHANES (2001–2010).
Main outcomes measures Circulating 25-OHD levels.
Results Multivariable linear regression and logistic 
regression models were used to evaluate the associations 
of self-reported LTPA with 25-OHD, adjusting for potential 
confounders. Due to the differences in LTPA measure, 
the analyses were conducted separately for 2001–2006 
and 2007–2010 data. We further estimated associations 
by indoor and outdoor activity in the 2001–2006 data. 
There were 1530 cancer survivors (mean age=60.5 
years, mean body mass index=28.6 kg/m2). The prevalent 
cancer sites were breast (19.3%), prostate (18.8%), cervix 
(10.4%) and colon (8.6%). Compared with inactive cancer 
survivors, being physically active was associated with 
higher circulating 25-OHD levels (8.07 nmol/L, 95% CI 
4.63 to 11.52) for 2001–2006 data. In the mutually 
adjusted model, higher outdoor activity (5.83 nmol/L, 
95% CI 1.64 to 10.01), but not indoor activity (2.93 nmol/L, 
95% CI −1.80 to 7.66), was associated with statistically 
significantly higher 25-OHD levels. The interaction 
between indoor and outdoor activities was, however, 
not significant (p=0.29). The only statistically significant 
association seen in the 2007–2010 data was among 
obese cancer survivors.
Conclusion Physical activity, particularly outdoor activity, 
is associated with higher 25-OHD levels in cancer 
survivors. In view of the possible beneficial effects of 
vitamin D on cancer prognosis, engaging in outdoor 
physical activity could provide clinically meaningful 
increases in 25-OHD levels among cancer survivors.
Background
There are >15.5 million cancer survivors 
in the USA and the number is expected 
to rise to 20 million by 2026.1 Identifying 
factors, particularly modifiable factors, that 
improve prognosis and survival in this rapidly 
expanding demographic group is, therefore, 
a high priority.
There is emerging evidence that vitamin D 
status is associated with improved cancer prog-
nosis and survival, particularly colorectal and 
breast cancers.2–5 Circulating 25-hydroxyvi-
tamin D (25-OHD) is the best indicator 
of overall vitamin D status because it has a 
long half-life, is unregulated by homeostatic 
systems in the body and reflects total vitamin 
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Research
Strengths and limitations of this study
 ► To the best of our knowledge, this is the first study to 
investigate the association of leisure-time physical 
activity (LTPA) with circulating 25-hydroxyvitamin 
D (25-OHD) levels in cancer survivors. We further 
compared associations by outdoor and indoor LTPA.
 ► The current study pooled data from cancer survivors 
in a nationally representative adult sample in the 
USA.
 ► This study controlled for a range of factors that are 
known to affect circulating 25-OHD levels.
 ► Study limitations include the following: (1) the cross-
sectional nature makes it impossible to determine 
a causal association; (2) season, an important 
determinant of 25-OHD levels, was categorised 
into two (winter and summer, rather than winter, 
summer, fall and spring); and (3) physical activity 
was self-reported.
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D from multiple determinants.6–9 However, it has been 
suggested that circulating 25-OHD level may be a surro-
gate or biological marker for lifestyle factors that impact 
cancer prognosis, notably physical activity.2 10 11 Physical 
activity, before and after cancer diagnosis, is associated 
with reduced mortality in cancer survivors,12–14 although 
the underlying mechanisms are still being elucidated. 
In cancer-free population, leisure-time physical activity 
(LTPA) is associated with an increase in circulating 
25-OHD levels, which is thought to reflect exposure to 
sunlight, a major determinant of circulating 25-OHD 
levels.15 In support, studies have reported higher 25-OHD 
levels for the same amount of outdoor compared with 
indoor physical activity,16 although others have not.17
Nevertheless, it has also been shown that physical 
activity and sun exposure may have independent effects 
on circulating 25-OHD levels, suggesting that indoor 
physical activity might be sufficient to increase circulating 
25-OHD levels through its effect on 25-OHD metabolism, 
such as 1,25-dihydroxyvitamin.18–21
To the best of our knowledge, no study has investi-
gated the associations of physical activity with circulating 
25-OHD levels in cancer survivors. Because physical 
activity declines after cancer diagnosis, findings in cancer-
free population may not apply to cancer survivors. Using 
data from the National Health and Nutrition Examination 
Survey (NHANES), our objectives are to (1) investigate 
the associations of LTPA with circulating 25-OHD levels 
in cancer survivors, and (2) determine whether associa-
tions differ by indoor and outdoor physical activity. Study 
findings could have implications for public health recom-
mendations in cancer survivors because physical inactivity 
and vitamin D insufficiency are prevalent among cancer 
survivors.22 23
MeThods
study population
The NHANES was designed to provide cross-sectional esti-
mates on the prevalence of health, nutrition and potential 
risk factors among the civilian non-institutionalised US 
population up to 85 years of age.24 In brief, NHANES 
surveys a nationally representative complex, stratified, 
multistage, probability clustered sample of about 5000 
participants each year in 15 counties across the country. 
The NHANES obtained approval from the National 
Center for Health Statistics Research Ethics Review Board 
and the participants provided written consent.
We extracted demographic information, measures of 
adiposity, smoking history, self-reported LTPA, circulating 
25-OHD levels and cancer diagnosis, and combined 
them into a single data set for each data collection wave. 
Participants were considered as cancer survivors if they 
answered ‘yes’ to the question ‘Have you ever been 
told by a doctor or other health professional that you 
had cancer or a malignancy of any kind?’ We excluded 
participants who had non-melanoma skin cancer. This 
interview question was only given to men and women 20 
years or older, and subsequently restricted the analysed 
sample to adult cancer survivors. We created a single data 
set for each wave of data from NHANES in 2001–2002, 
2003–2004, 2005–2006, 2007–2008 and 2009–2010, and 
excluded those who were never diagnosed with cancer or 
were pregnant (figures 1 and 2).
circulating 25-ohd levels
The process of blood collection is detailed in the NHANES 
Laboratory/Medical Technologist Procedures Manual.25 
Participants who received chemotherapy within the last 
4 weeks were excluded from blood collection in the 
NHANES study. Blood samples were collected, processed, 
stored and shipped to University of Washington, Seattle 
for testing. The lab method measuring 25-OHD for 2007–
2010 changed from 2005 to 2006 and earlier in NHANES, 
and has been described previously.26 Briefly, circulating 
25-OHD concentrations were measured at the National 
Center for Environmental Health, Centers for Disease 
Control and Prevention, Atlanta, Georgia, using the 
DiaSorin RIA kit (Stillwater, Minnesota, USA) between 
2001 and 2006. We converted the 25-OHD data in 2001–
2006 using provided regression to equivalent 25-OHD 
measurement from a standardised liquid chromatogra-
phy-tandem mass spectrometry method, which was used 
in the analysis of 25-OHD in NHANES 2007–2010 data. 
This standardisation procedure therefore ensures that 
25-OHD data are comparable between 2001–2006 and 
2007–2010.
sociodemographic characteristics
Sociodemographic characteristics including age, sex, 
race and ethnicity, and smoking status were extracted. 
Based on self-reported race and ethnicity, participants 
were classified into one of the three racial/ethnic groups: 
non-Hispanic white, non-Hispanic black, and Hispanic 
and others. We classified participants into three groups: 
never smokers (did not smoke 100 cigarettes and do not 
smoke now), former smokers (smoked 100 cigarettes in 
life and do not smoke now) and current smokers (smoked 
100 cigarettes in life and smoke now).
Body mass index
Weight and height were measured at the time of physical 
examination in a mobile examination centre (MEC) or 
in the participant’s home. The measurements followed 
standard procedures and were carried out by trained 
technicians using standardised equipment. Body mass 
index (BMI) was calculated as weight in kg/(height in 
metres).2 We categorised study participants into standard 
BMI categories: underweight (<18.5 kg/m2), normal 
weight (18.5–24.9 kg/m2), overweight (25.0–29.9 kg/
m2) and obese (≥30.0 kg/m2). For analytic purposes, we 
combined those who were underweight and those who 
had normal weight into one category (≤25 kg/m2).
season of blood draw
Blood samples were collected at the time of physical 
examination in an MEC or in the participant’s home. 
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Figure 1 Participants’ flow chart: cancer survivors aged 20 years or older from the National Health and Nutrition Examination 
Survey (NHANES) (2001–2006). 25-OHD, 25-hydroxyvitamin D.
Season of blood draw was determined from the docu-
mented month of physical examination. Months were 
reported in two groups: 1 November through 30 April, or 
1 May through 31 October, and classified into winter or 
summer, respectively.16
dietary vitamin d supplement use
Information on dietary vitamin D supplement was 
retrieved from the 30-day dietary supplement data set in 
the 2001–2006 and 2007–2010 data. In the 2001–2006 
data set, we obtained data on individual product for 
participants who reported taking vitamin supplement, 
and linked to the Dietary Supplements Ingredient Data-
base.27 Products’ ingredients that contained vitamin D 
were aggregated for each participant, and then catego-
rised into a binary variable (yes/no) for dietary vitamin 
D supplement use assessment. In 2007–2010 data, aggre-
gated information on dietary supplement use (including 
vitamin D supplement use) was available, thus was used 
to determine participants’ dietary vitamin D supplement 
use (yes/no).
self-reported LTPa
The assessment on self-reported physical activity for 
2007–2010 changed from 2005 to 2006 and earlier. There 
is no conversion provided between the two assessments; 
therefore, analyses for LTPA were conducted separately 
for the 2001–2006 and 2007–2010 data.
In the 2001–2006 data, participants self-reported 
specific LTPA in the past 30 days from a list of 48 activities, 
if they engaged in certain activities, and the frequencies 
and durations of these activities. Each activity was coded 
into a metabolic equivalent task (MET) score based on the 
2011 Compendium of Physical Activities, a valid and glob-
ally used instrument to quantify the energy expenditure 
of physical activity in adults.28 For each reported activity, 
MET-minutes per week (MET-min/week) were calculated 
by multiplying the MET value of each reported activity by 
the minutes spent in the activity per 7 days. Overall LTPA 
was summarised as the total MET-min/week of all reported 
activities.29 Cancer survivors were classified as inactive (0 
MET-min/week), insufficiently active (<750 MET-min/
week) and sufficiently active (≥750 MET-min/week) 
based on the standard definition.29 In addition, we 
categorised each of the 48 listed activities into outdoor 
(eg, walking, jogging, fishing) or indoor (eg, aerobics, 
bowling, weights) activity. Activities that could be either 
indoor or outdoor (eg, bicycling, swimming) were clas-
sified as indoor to ensure a conservative estimation of 
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Figure 2 Participants’ flow chart: cancer survivors aged 20 years or older from the National Health and Nutrition Examination 
Survey (NHANES) (2007–2010). 25-OHD, 25-hydroxyvitamin D.
the associations between outdoor LTPA and 25-OHD. 
Both indoor and outdoor LTPAs were summarised in 
MET-min/week, then classified as inactive (0 MET-min/
week), insufficiently active (<450 MET-min/week) and 
sufficiently active (≥450 MET-min/week). A cut-off 
lower than 750 MET-min/week was used for indoor and 
outdoor activities, given they are subsets of overall LTPA. 
We used 450 MET-min/week as the cut-off given that it is 
the minimal goal of weekly LTPA.29
In the 2007–2010 data, participants self-reported their 
daily activities, leisure-time activities and sedentary activi-
ties using questions based on the Global Physical Activity 
Questionnaire.30 Levels of LTPA were calculated as the 
minutes per week that participants reported partici-
pating in moderate-to-vigorous-intensity physical activity 
(MVPA). Participants reported the number of days and 
minutes spent in moderate recreational and vigorous 
recreational activities in a typical week by answering 
the following questions: ‘In a typical week, on how 
many days do you do vigorous-intensity sports, fitness or 
recreational activities?’ ‘Minutes vigorous recreational 
activities’, and ‘In a typical week, on how many days do 
you do moderate-intensity sports, fitness or recreational 
activities?’ ‘Minutes moderate recreational activities’. 
We summarised the total number of minutes for both 
activities, where the number of minutes spent in vigor-
ous-intensity physical activity was doubled and added to 
the number of minutes of moderate-intensity physical 
activity to approximately equal the MET value.31 Cancer 
survivors were classified as inactive (0 min/week MVPA), 
insufficiently active (<150 min/week MVPA) and suffi-
ciently active (≥150 min/week MVPA) based on the 
physical activity guidelines for cancer survivors.32
statistical analysis
Survey analysis procedures were used to account for the 
sample weights (MEC exam weight), stratification and 
clustering of the complex sampling design to ensure 
nationally representative estimates. Information on socio-
demographic characteristics, weight, height, season of 
blood draw and self-reported LTPA was complete among 
cancer survivors who had available data on circulating 
25-OHD levels. We calculated the descriptive statistics 
for participants’ characteristics and LTPA categories by 
25-OHD levels in quintiles separately in 2001–2006 data 
and 2007–2010 data. We summarised weighted means 
and SEs for continuous variables, and weighted propor-
tions for categorical variables.
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We estimated linear associations between LTPA and 
25-OHD levels in both 2001–2006 and 2007–2010 data. 
The multivariable linear regression models for LTPA 
were adjusted for age, sex, race, BMI, smoking status 
and season of blood draw. In the 2001–2006 data, we 
further estimated the linear associations between LTPA 
and 25-OHD separately by indoor and outdoor activi-
ties. Χ2test indicated significant difference (p<0.001) 
between indoor and outdoor activities. In the multi-
variable linear regression models, we simultaneously 
adjusted for both activities. We tested for differences 
between the indoor and outdoor effects by including 
both in the regression model and testing for interac-
tion. We examined the normality of residuals by kernel 
density estimate and standardised normal probability 
plots for all the linear regression models. Continuous 
25-OHD data were categorised as low (<50 nmol/L) and 
high (≥50 nmol/L) 25-OHD based on definitions of 
vitamin D insufficiency.30
To calculate the prevalence ratios (PRs) of high 
25-OHD level (≥50 nmol/L) across LTPA categories, we 
first calculated prevalence ORs (PORs) for each category 
in multivariable logistic regression models. Since the 
PORs do not approximate the PRs for common outcome 
(25-OHD ≥50 nmol/L), we used the baseline prevalence 
to correct the PORs and 95% CIs based on existing 
method to obtain reliable PR estimates.33 We further 
conducted the following sensitivity analyses: (1) using 
BMI as a continuous variable in the regression models; 
(2) stratification by BMI category; (3) classifying activi-
ties that could be either indoor or outdoor (eg, bicycling, 
swimming) as outdoor activities; and (4) classifying activi-
ties that could be either indoor or outdoor (eg, bicycling, 
swimming) as half–half (MET-min/week) to indoor and 
outdoor activities.
All statistical significance was set at p<0.05. All statistical 
analyses were performed using Stata V.14.0.
resuLTs
Our study population consisted of 1530 cancer survi-
vors who had data on circulating 25-OHD levels. The 
most prevalent cancer sites were breast cancer (19.3%), 
prostate (18.8%), cervix (10.4%) and colon (8.6%). 
Participants’ mean age at the time of baseline examina-
tion was 60.5 years, and their mean BMI was 28.6 kg/
m2. Circulating 25-OHD levels were significantly higher 
among those who reported dietary vitamin D supplement 
use than those who did not in both 2001–2006 (68.82 vs 
56.74 nmol/L, p<0.001) and 2007–2010 data (83.73 vs 
60.88 nmol/L, p<0.001). We observed statistically signif-
icant differences in circulating 25-OHD levels for most 
characteristics, except for age and sex (2001–2006 in 
table 1 and 2007–2010 in table 2). Cancer survivors who 
were obese, non-Hispanic black or smokers had lower 
25-OHD levels than those who had normal weight, were 
non-Hispanic white/Hispanic and were non-smokers, 
respectively.
associations between LTPa and circulating 25-ohd levels
Tables 3 and 4 summarise both the non-adjusted and 
adjusted associations between LTPA and circulating 
25-OHD in linear regression and logistic regression 
models, respectively. Because LTPA measure differed 
between 2001–2006 and 2007–2010 and there is no 
conversion between the two, it is not possible to compare 
the findings between two study phases directly. Cancer 
survivors who were sufficiently active had higher circu-
lating 25-OHD levels than those who were inactive in 
univariate analyses, and these findings were maintained in 
multivariable analyses in the 2001–2006 data, but not the 
2007–2010 data. This translated to 8.07 nmol/L (95% CI 
4.63 to 11.52) higher 25-OHD levels in 2001–2006 phase 
in the multivariable-adjusted models. Furthermore, the 
comprehensive data on a list of 48 activities collected in 
2001–2006 allowed us to extend the analyses to compare 
between indoor and outdoor LTPA in relation to 25-OHD 
levels. In the non-adjusted models (table 3), higher levels 
of indoor and outdoor LTPA both were associated with 
higher 25-OHD levels. However, in multivariable-ad-
justed models (that also mutually adjusted for indoor 
and outdoor LTPA), the association was only statisti-
cally significant among cancer survivors who engaged in 
outdoor LTPA (5.83 nmol/L, 95% CI 1.64 to 10.01). The 
interaction between indoor and outdoor activities was 
not significant (p=0.29). Analyses using logistic regres-
sion models were supportive. Our findings were similar 
when we classified activities that could be either indoor 
or outdoor (eg, bicycling, swimming) as outdoor activities 
(6.39 nmol/L, 95% CI 2.85 to 9.94), and classifying these 
activities as half–half (MET-min/week) to indoor and 
outdoor activities (7.26 nmol/L, 95% CI 2.88 to 11.64) 
(data not shown).
Likewise, we observed similar results in sensitivity anal-
yses using BMI as a continuous variable; higher 25-OHD 
levels were associated with LTPA in the overall analyses 
(7.74 nmol/L, 95% CI 4.53 to 10.95) and among those 
who engaged in outdoor LTPA (5.82 nmol/L, 95% CI 
1.69 to 9.95) (data not shown). In stratified analyses, asso-
ciations of LTPA with higher circulating 25-OHD levels 
were retained in the obese group in the 2001–2006 data 
(7.10 nmol/L, 95% CI 2.51 to 11.70, outdoor LTPA) as well 
as 2007–2010 data (13.91 nmol/L, 95% CI 3.86 to 23.96, 
overall LTPA) (see online supplementary 1). The strati-
fied analyses should, however, be interpreted cautiously 
because the relatively small number of participants in the 
different strata may not allow for very robust effect esti-
mates. Outdoor LTPA was lower in non-Hispanic black 
(69.2% inactive vs 51.5% inactive among non-Hispanic 
whites, and 43.2% inactive among Hispanics) (data not 
shown).
discussion
We observed that being physically active was associated 
with higher circulating 25-OHD levels in a nationally 
representative sample of cancer survivors. Further 
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analyses showed that the elevated 25-OHD levels were 
only statistically significant among cancer survivors who 
engaged in outdoor physical activity.
To the best of our knowledge, this is the first study to 
evaluate the associations of physical activity with circu-
lating 25-OHD levels in cancer survivors. Our findings 
are, however, similar to what has been reported among 
non-cancer participants enrolled in NHANES (1988–
1994).16 Scragg and Camargo reported a 9.6 nmol/L 
increase in 25-OHD levels among participants who 
engaged in outdoor LTPA compared with those who did 
not engage in outdoor LTPA. The increase in 25-OHD 
levels associated with outdoor LTPA is higher than what 
we observed in our study population (5.83 nmol/L higher 
25-OHD). This could be due to the different ways LTPA 
was categorised. The most active group in their study 
translates to participating daily in outdoor activity, while 
only 5.6% (weighted proportion) of cancer survivors 
in our sample achieved this physical activity level. To 
compare at an equivalently active level, our findings of 
a 5.83 nmol/L increase in cancer survivors are similar to 
6.1 nmol/L higher 25-OHD level in individuals who were 
at a similar activity level (engaged in 13–30 times outdoor 
LTPA per month) reported by Scragg and Camargo.16 
Data from trials have shown that each 40 IU of vitamin 
D consumed increases serum 25-OHD concentrations 
by 0.53 nmol/L in adults.34 The recommended dietary 
vitamin D allowance for adults in the USA is 600 IU, which 
is expected to increase circulating 25-OHD levels by 
15 nmol/L. Thus, our findings (a 5.83 nmol/L increase) 
suggest that engaging in outdoor LTPA could provide 
clinically meaningful increases in 25-OHD levels among 
cancer survivors. A more recent analysis using NHANES 
2003–2006 data reported increasing level of 25-OHD 
is associated with higher level of objectively measured 
moderate-to-vigorous physical activity, but the association 
was not stronger for outdoor LTPA compared with indoor 
when using self-reported data.17
It is unclear whether physical activity has direct or 
indirect effects on 25-OHD levels. Sun exposure is the 
major determinant of circulating 25-OHD levels; hence, 
it is possible that physical activity may indirectly impact 
25-OHD levels through increased sun exposure asso-
ciated with outdoor activity7 among active individuals, 
yet few studies have measured activities specifically to 
outdoor, or able to adjusted for sun exposure.16 17 35 36 
On the other hand, physical activity may directly impact 
25-OHD metabolism. Zittermann and colleagues18 
reported higher calcium absorption rates and plasma 
calcritrol levels in exercise-trained young men compared 
with age-matched sedentary controls. Similarly, in a small 
study, young men who underwent muscle-building exer-
cise (indoor) for at least 1 year had higher circulating 
25-OHD, Gla protein and 1,25-dihydroxyvitamin levels 
compared with age-matched controls who received 
constant daily diet same as the exercise group.20 However, 
whether this mechanism operates in cancer survivors 
is unclear because of the physiological, biological and 
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Table 3 Associations between LTPA and circulating 25-OHD level from unadjusted and multivariable linear regression models 
among cancer survivors aged 20 years or older from the NHANES (2001–2010)
2001–2006* (n=793)
Circulating 25-OHD (nmol/L)
UnadjustedBeta coefficient (95% CI)
Adjusted†Beta coefficient 
(95% CI)
LTPA
  Inactive Reference Reference
  Insufficiently active 7.36 (2.65 to 12.07) 3.63 (−0.69 to 7.95)
  Sufficiently active 12.16 (7.29 to 17.04) 8.07 (4.63 to 11.52)
  p For trend <0.001 <0.001
Outdoor physical activity
  Inactive Reference Reference
  Insufficiently active 9.10 (5.15 to 13.04) 6.17 (1.74 to 10.59)
  Sufficiently active 8.84 (4.16 to 13.52) 5.83 (1.64 to 10.01)
  p For trend <0.001 0.005
Indoor physical activity
  Inactive Reference Reference
  Insufficiently active 3.15 (−1.63 to 7.94) −1.22 (−4.97 to 2.52)
  Sufficiently active 8.22 (2.50 to 13.93) 2.93 (−1.80 to 7.66)
  p For trend 0.004 0.23
2007–2010* (n=737)
Circulating 25-OHD (nmol/L)
UnadjustedBeta coefficient (95% CI)
Adjusted†Beta coefficient(95% 
CI)
LTPA
  Inactive Reference Reference
  Insufficiently active 8.80 (−2.67 to 20.26) 5.70 (−4.19 to 15.6)
  Sufficiently active 12.04 (5.24 to 18.84) 5.73 (−1.68 to 13.15)
  p For trend 0.001 0.11
*LTPA data analysed separately due to the changes in self-reported LTPA measures from wave 2005–2006 to wave 2007–2008.
†Adjusted for age, sex, race, body mass index, smoking status and dietary vitamin D supplement use.
25-OHD, 25-hydroxyvitamin D; LTPA, leisure-time physical activity; NHANES, National Health and Nutrition Examination Survey.
behavioural alterations associated with cancer and cancer 
treatment.32
We observed statistically significant higher circulating 
25-OHD levels associated with outdoor, but not with 
indoor, LTPA in the mutually adjusted model. Neverthe-
less, no statistically significant interaction between indoor 
and outdoor LTPA was observed. It is likely that LTPA 
influences 25-OHD via multiple pathways, possibly both 
an indirect effect due to sun exposure and a direct impact 
on 25-OHD metabolism. However this warrants further 
investigation using precise measures of physical activity37 
and taking into consideration sun exposure and other 
vitamin D metabolites.
We observed that obese cancer survivors who were 
active had higher circulating 25-OHD levels. Obesity 
is believed to induce low circulating 25-OHD levels 
through volumetric dilution of vitamin D in the excessive 
adipose tissue.38 Given that obese cancer survivors are at 
higher risk of vitamin D deficiency compared with the 
non-obese,39 40 the present findings suggested engaging in 
physical activity might be particularly important to main-
tain or increase circulating 25-OHD levels among obese 
cancer survivors. Future studies are needed to confirm 
these findings using more precise measures of adiposity 
(eg, body fat percentage) in a larger study population.
The association between LTPA and dietary vitamin D 
supplement use appeared to differ between 2001–2006 
data (p=0.19) and 2007–2010 data (p=0.03), although 
the prevalence of dietary vitamin D supplement use was 
similar in two study phases (51.4% vs 51.5%). In the 
2007–2010 data, active cancer survivors are more likely 
to report dietary vitamin D supplement use compared 
with inactive ones. Thus, the non-significant findings of 
LTPA and circulating 25-OHD levels could arise from the 
change in self-reported LTPA measures from 2001–2006 
to 2007–2010 data.
The main strength of this analysis is pooling cancer 
survivors from a nationally representative adult sample 
in the USA. We aggregated five waves’ data and achieved 
a fairly sizeable sample. In addition, we controlled for a 
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Table 4 Associations between LTPA and circulating 25-OHD level from unadjusted and adjusted logistic regression models 
among cancer survivors aged 20 years or older from the NHANES (2001–2010)
2001–2006* Circulating 25-OHD ≥50 nmol/L (n=534)
Reference Circulating 25-OHD <50 nmol/L 
(n=259)
UnadjustedPrevalence ratio 
(95% CI)†
Adjusted‡Prevalence ratio 
(95% CI)†
LTPA
  Inactive Reference Reference
  Insufficiently active 1.19 (1.02 to 1.33) 1.10 (0.88 to 1.27)
  Sufficiently active 1.36 (1.30 to 1.45) 1.32 (1.19 to 1.41)
  p For trend <0.001 <0.001
Outdoor physical activity
  Inactive Reference Reference
  Insufficiently active 1.21 (1.10 to 1.30) 1.16 (1.01 to 1.27)
  Sufficiently active 1.24 (1.11 to 1.33) 1.22 (1.06 to 1.32)
  p For trend 0.001 0.009
Indoor physical activity
  Inactive Reference Reference
  Insufficiently active 1.19 (0.99 to 1.33) 1.10 (0.87 to 1.27)
  Sufficiently active 1.21 (1.05 to 1.33) 1.07 (0.88 to 1.23)
  p For trend 0.006 0.32
2007–2010* Circulating 25-OHD ≥50 nmol/L (n=531)
Reference Circulating 25-OHD <50 nmol/L 
(n=206)
UnadjustedPrevalence ratio 
(95% CI)
Adjusted†Prevalence ratio 
(95% CI)
LTPA
  Inactive Reference Reference
  Insufficiently active 1.15 (0.97 to 1.26) 1.14 (0.92 to 1.27)
  Sufficiently active 1.22 (1.07 to 1.30) 1.13 (0.90 to 1.27)
  p For trend 0.008 0.18
*LTPA data analysed separately due to the changes in self-reported LTPA measures from wave 2005–2006 to wave 2007–2008.
†Prevalence ratio and 95% CIs were corrected using prevalence OR and prevalence of high 25-OHD level (≥50 nmol/L) in reference groups.
‡Adjusted for age, sex, race, body mass index, smoking status and dietary vitamin D supplement use.
25-OHD, 25-hydroxyvitamin D; LTPA, leisure-time physical activity; NHANES, National Health and Nutrition Examination Survey.
range of factors that are known to affect the circulating 
25-OHD levels. Further, we were able to compare associa-
tions of LTPA with 25-OHD by outdoor and indoor LTPA, 
thereby providing further insights on the associations of 
LTPA with 25-OHD levels.
There are a number of limitations to this study. First, 
the cross-sectional nature of this study makes it impos-
sible to determine a causal association. The debate on 
whether vitamin D deficiency is a risk factor for mortality 
or an indicator of good health is ongoing.41 42 It is possible 
that active cancer survivors were more active because of 
better health status than those who were inactive. Thus, 
the higher 25-OHD levels in active cancer survivors might 
be an indicator of better overall health. Second, season, 
an important determinant of 25-OHD levels, was only 
available in two categories. Solar radiation, required for 
skin to synthesise vitamin D, is weaker in winter compared 
with summer. However, there were no statistically signif-
icant differences between winter (southern states) and 
summer (northern states) 25-OHD levels in our study 
population, probably owing to the timing of blood collec-
tion in each region. The NHANES study collected blood 
samples in the southern states during winter and in the 
northern states during summer. Third, we were not able 
to conduct analyses stratified by cancer type or time since 
diagnosis because of the limited number of individual 
cancers. Finally, physical activity was self-reported. Partici-
pants who received chemotherapy within the last 4 weeks 
were excluded from blood collection within the NHANES 
study. Chemotherapy-associated reduction of circulating 
25-OHD level has been documented previously.43–45 
Therefore our findings might not be generalisable to 
patients receiving chemotherapy.
Our findings of an association between LTPA and 
25-OHD, which was stronger for outdoor LTPA compared 
with indoor LTPA, have implications for public health 
recommendations in cancer survivors. Although the 
casual relationship of 25-OHD with cancer survival is yet 
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unclear, strong evidence supports the benefits of phys-
ical activity in improved cancer survival and the quality 
of life during survival.37 46 Our findings suggest that 
25-OHD might be a surrogate marker of physical activity 
that accounts for the direct and indirect effects of LTPA, 
particularly outdoor.7 16 The proportion of cancer survi-
vors in NHANES who did not engage in any LTPA was 
high, especially in the 2007–2010 (53.3%) compared with 
the 2001–2006 wave (38.3%). This observed decline in 
LTPA might be attributed to the differences in measures 
and may not reflect an actual change in LTPA levels, that 
is, the 2001–2006 measure comprised 48 activity items 
while the 2007–2010 measure queries general physical 
activity participation. These differences in measures may 
also contribute to the non-significant findings observed 
in the 2007–2010 data. In fact, an increase in the phys-
ical activity level in the US population from 2001 to 2011 
has been reported from the  The Behavioral Risk Factor 
Surveillance System (BRFSS) data,47 although this trend 
may not hold true in cancer survivors. Guidelines from 
the American Cancer Society32 and American College of 
Sports Medicine48 suggest that cancer survivors should 
follow the physical activity guidelines for Americans 
with specific exercise programming adaptations based 
on disease-related and treatment-related adverse effects. 
However, physical activity levels in these populations are 
critically low during and after treatment.49 Physical activity 
interventions in cancer survivors may consider including 
early morning (before 11:00) outdoor activities for about 
15 min. Notably, given the well-documented differences 
in cancer prognosis between non-Hispanic blacks and 
other racial/ethnic groups, and the emerging associa-
tions of vitamin D with cancer prognosis, physical activity 
interventions incorporating outdoor activities might be 
particularly important for cancer survival among non-His-
panic blacks.
In conclusion, physical activity, particularly outdoor 
physical activity, is associated with higher 25-OHD levels 
in cancer survivors. This adds to the potential health 
benefits of being physically active. Non-Hispanic black 
cancer survivors, who are more likely to have vitamin D 
deficiency, were less likely to engage in outdoor LTPA. 
In view of the possible beneficial effects of vitamin D on 
cancer prognosis, engaging in outdoor physical activity 
could provide clinically meaningful increases in 25-OHD 
levels among cancer survivors.
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